These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2566639)

  • 41. [Tissue polypeptide antigen in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
    Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical significance of sialyl SSEA-1 assay as a tumor marker].
    Endo J; Nagaoka S; Kannagi R
    Nihon Rinsho; 1990 Feb; 48 Suppl():1008-12. PubMed ID: 1972417
    [No Abstract]   [Full Text] [Related]  

  • 43. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
    Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A
    G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tumor marker combination versus second-look operation in ovarian cancer].
    Lahousen M; Stettner H; Pürstner P; Pickel H
    Zentralbl Gynakol; 1990; 112(9):561-6. PubMed ID: 2378187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer].
    Lapchenkov VI; Dudarev AL; Vinokurov VL; Iurkova LE; Barbanel EIu
    Vestn Rentgenol Radiol; 1993; (5):30-1. PubMed ID: 7801580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in serum levels of gynecological tumor markers throughout the period from early gestation to puerperium].
    Sugawara T; Tanaka T; Sato H; Hanatani K; Okuyama K; Shinkai N; Sakuragi N; Makinoda S; Fujimoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):145-51. PubMed ID: 1707431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of the levels of CA125, CEA and CA19-9 in the cervical mucus samples obtained at various phases of the menstrual cycle and with inflammatory diseases of the uterine cervix].
    Nanbu Y; Fujii S; Konishi I; Nonogaki H; Kobayashi F; Sagawa N; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Oct; 40(10):1519-24. PubMed ID: 3225482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical usefulness of tumor markers associated with pancreatic cancer].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of tumor marker in ovarian dermoid cyst].
    Mikuni M; Makinoda S; Tanaka T; Okuda T; Domon H; Fujimoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):479-84. PubMed ID: 2373920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical usefulness of serum sialyl Le(x)-i measurement in patients with ovarian cancer].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):15-9. PubMed ID: 2564410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum levels of six tumor markers in patients with benign and malignant gynecological disease.
    Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sato T; Takamizawa H; Wiklund B
    Arch Gynecol Obstet; 1988; 243(2):61-8. PubMed ID: 3401042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.